EXHIBIT 2.3
STOCKHOLDER SUPPORT AGREEMENT
THIS STOCKHOLDER SUPPORT AGREEMENT (this “Agreement”) is entered into as of January 28, 2020, by and among Histogen Inc., a Delaware corporation (“Company”), Conatus Pharmaceuticals Inc., a Delaware corporation (“Parent”), and the undersigned stockholders of the Company (collectively, solely in each stockholder’s capacity as a stockholder of the Company, the “Stockholders”).
WHEREAS, as of the date hereof, each Stockholder is the sole record and beneficial owner of and has the sole power to vote (or to direct the voting of) the number of shares of Company common stock, par value $0.001 per share (such stock, the “Common Stock”, and such shares, the “Common Shares”), and the number of shares of Company preferred stock, par value $0.001 per share (such stock, the “Preferred Stock”, and such shares, the “Preferred Shares”), set forth on such Stockholder’s signature page hereto (such Common Shares and Preferred Shares, the “Original Shares”);
WHEREAS, the Company, Parent and Chinook Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), are concurrently entering into an Agreement and Plan of Merger and Reorganization, dated on or about the date hereof (as amended from time to time in accordance with the terms thereof, the “Merger Agreement”), attached hereto asExhibit A, pursuant to which Merger Sub shall be merged with and into the Company, with the Company continuing as the surviving corporation thereafter (the “Merger”);
WHEREAS, the adoption of the Merger Agreement and the transactions contemplated thereby requires the written consent or affirmative vote of (a) the holders of a majority of the shares of Common Stock and Preferred Stock outstanding on the record date for the consent thereto or the vote thereon and entitled to vote thereon, voting as a single class, with each such holder of shares of Preferred Stock having a number of votes equal to the whole number of shares of Common Stock into which such holder’s shares of Preferred Stock were convertible immediately after the close of business on such record date, and (b) the holders of a majority of the shares of each series of Preferred Stock outstanding on such record date for consent thereto or the vote thereon and entitled to vote thereon, voting together as a separate class on anas-converted to Company Common Stock basis (collectively, the “Required Company Stockholder Vote”);
WHEREAS, the Company and Parent have incurred, and may continue to incur, substantial expenses related to the evaluation, negotiation and consummation of the Merger, the Merger Agreement and the related Transaction Documents;
WHEREAS, the execution and delivery of this Agreement by the Stockholders is a condition precedent to the execution and delivery by Parent of the Merger Agreement and constitutes a material inducement for Parent therefor; and
WHEREAS, each Stockholder is entering into this Agreement as an inducement to the Company and Parent to enter into the Merger Agreement and consummate the transactions contemplated thereby, transactions from which such Stockholder believes it will derive substantial benefits through its ownership interest in the Company.
-1-